Iain Stuart - 31 Dec 2024 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Issuer symbol
VYNE
Transactions as of
31 Dec 2024
Net transactions value
-$16,271
Form type
4
Filing time
02 Jan 2025, 17:45:10 UTC
Previous filing
02 Oct 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $16,271 -4,857 -3.6% $3.35 128,637 31 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.